InsidersTradesSigma
Prostatype Genomics AB: insider trades · Finland · FIN-FSA
FI:prostatype-genomics-ab-3eb36cSE0024990071FI·FIN-FSAMcap 41M€Healthcare
Discover the full management transaction log of Prostatype Genomics AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Prostatype Genomics AB has recorded 1 insider filings. Market capitalisation: €41.3m. The latest transaction was reported on 11 June 2025 — Purchase. Among the most active insiders: Michael Häggman. The full history is openly available.
1
Insider Decl.
0
Thresholds
€20,827
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.70 €
Analyst consensus
Income statement
Revenue594 k€
Gross profit594 k€100% margin
Net income−44.5 M€-7492.1% margin
Valuation
P/Book1.6x
Beta1.52
Balance sheet & cash
Market cap41.3 M€
Total debt67 k€
Free Cash Flow−37.2 M€
Profitability & ownership
ROE-148.3%
ROA-52.4%
% insiders28.8%
% institutions0.0%
Last declaration on 11 June 2025
Declarations0 total
No declarations found
0 of 0 declarations